Pro Traders Forum

[TradeForProfits]

$EDXC 2020 taking advantage as more states legalize #cannabis:

http://www.stockmarketpress.com/cannabis-may-become-legal-in-more-states-in-2020/

[gumzsa]

gm pros

[TradeForProfits]

$EDXC article out discussing recent progress:

https://www.marketwatch.com/press-release/growing-cbd-markets-ready-for-the-next-phase-massive-consumer-demand-answered-2020-01-22?mod=mw_quote_news

Growing CBD Markets Ready for the Next Phase: Massive Consumer Demand Answered
Published: Jan 22, 2020 8:39 a.m. ET


Jan 22, 2020 (Stock Market Press via COMTEX) -- Until recently, CBD was found in specialist shops, at stratospheric prices then regulations were lifted and consumer education began. This education has spurred a monstrous consumer demand for CBD products across all product lines, from drops to edibles, from skin creams to pet products.

Projections from well known research companies, like the Brightfield Group, foresee 100% year over year increases for the growing CBD markets. Figures like these bring to light just how massive consumer demand is and further education is only going to increase these figures. Additionally, we can see why a company like CBD Unlimited, Inc. EDXC, -1.39% is not only experiencing massive growth but forecasts this to be even higher over the next few years.

Tickers: CBD Unlimited, Inc. EDXC, -1.39%, Sugarmade, Inc. SGMD, -1.82%, Aurora Cannabis Inc. ACB, -2.99% (ACB), Canopy Growth Corporation CGC, -0.85%, Tilray, Inc. TLRY, -1.04%, Aphria, Inc. APHA, +0.82%

New York, NY, January 22, 2020 - Stock Market Press is a leading financial news company that delivers up to date news. Recap of eruptive news this week includes CBD Unlimited, Inc. EDXC, -1.39% reaching over 5,500 mass pharmacy and mass retail stores. Furthermore, we discuss Sugarmade, Inc. SGMD, -1.82%, Aurora Cannabis Inc. ACB, -2.99% (ACB), Canopy Growth Corporation CGC, -0.85%, Tilray, Inc. TLRY, -1.04%, Aphria, Inc. APHA, +0.82%.

Growing CBD markets

We mentioned edibles earlier, one of many CBD markets that's seeing huge interest by the general consumer, an area that CBD Unlimited, Inc. EDXC, -1.39% highlighted in their recent PR, an excerpt of which is included here:

CBD Unlimited Announces Fiscal Year-End Financial Results; Year-Over-Year Revenues Grow 88 Percent

Fiscal Year 2019 Milestones and Highlights:

International Expansion

* Cleared to Distribute CBD Products in Puerto Rico and South Africa.

* Accelerated registration in multiple international markets as the Company prepares for additional targeted channels abroad.

Increased Store Count Growth

* Surpassed year-end store goal by three months to more than 5,000 stores nationwide in mass pharmacy and mass retail markets.

* Accelerated store growth in the current quarter as stores are expanding their state rollout schedule. New contracted distributors are opening chain stores at 200-500 stores per launch.

* New Premium Blue Line BalmX and MistX installed in approximately 1,500 stores across 10 states.

* Established the foundation to service increased demand and to onboard stores on demand.

Product Innovation

* Closed deal with leading chocolate manufacturer, First Foods Group, Inc. (FIFG) to collaborate on premium hemp-based CBD food products.

* Invested and manufactured six Premium Blue Line SKUs at 35,000 units each.

* Reported wholesale value of the 6 premium products is valued over $5.5 million.

E-Commerce Advancement

* Reestablished Processing with two Major American Merchants.

* Increased its fulfillment capacity as the Company continues to grow its e-commerce presence.

Increased Tradeshow Presence

* Showcased its products at ECRM's Hemp/ CBD Health and Beauty Care Program where the Company was introduced to major retail buyers who extended commitments to the Company.

* Tradeshows in 2019 generated interest in the Company's products from approximately 50 leading retail stores across America.

Capital Markets

* Completed an audit of its financial statements for fiscal years 2018 and 2017 in order to pursue an up-listing to a higher OTC Market tier.

* Carries inventory on its books until the inventory is sold. The sale converts inventory into revenue instead of accounts receivable in certain Fortune 50 retailers.

Sugarmade, Inc. SGMD, -1.82% closed green on Tuesday after last weeks unexpected news of rescission of a recently closed, and long awaited, acquisition. Management saw the changing cannabis landscape would have them, and shareholders, better served headed in a new direction, which plans are already moving forward at a blistering pace.

The long road back for Aurora Cannabis Inc. ACB, -2.99% (ACB) could be getting started as the past week saw them climb back to 'life' after hitting $1.50 for a low. Aurora Cannabis Inc. ACB, -2.99% (ACB) closed down 5.6% on 38M vol traded.

Canopy Growth Corporation CGC, -0.85%, much like Aurora Cannabis Inc. ACB, -2.99% (ACB), while closing red for the day, saw stability return to the market during the last few hours of trading. One to watch here as it tests the $26 pivot point.

Recently announced expansion of their global leadership team saw Tilray, Inc. TLRY, -1.04% rally over the past week, closing up $5 at $21.09, from the chart bottom.

News of Aphria, Inc. APHA, +0.82% EU GMP certification gave the market a confirmation that business is set for growth, testing the resistance at the $5.60 level, a key trend reversal confirmation point.

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

[TradeForProfits]

$EDXC $CBD products now in over 5,500 big box stores:

https://www.marketwatch.com/press-release/growing-cbd-markets-ready-for-the-next-phase-massive-consumer-demand-answered-2020-01-22?mod=mw_quote_news

Growing CBD Markets Ready for the Next Phase: Massive Consumer Demand Answered
Published: Jan 22, 2020 8:39 a.m. ET


Jan 22, 2020 (Stock Market Press via COMTEX) -- Until recently, CBD was found in specialist shops, at stratospheric prices then regulations were lifted and consumer education began. This education has spurred a monstrous consumer demand for CBD products across all product lines, from drops to edibles, from skin creams to pet products.

Projections from well known research companies, like the Brightfield Group, foresee 100% year over year increases for the growing CBD markets. Figures like these bring to light just how massive consumer demand is and further education is only going to increase these figures. Additionally, we can see why a company like CBD Unlimited, Inc. EDXC, -1.39% is not only experiencing massive growth but forecasts this to be even higher over the next few years.

Tickers: CBD Unlimited, Inc. EDXC, -1.39%, Sugarmade, Inc. SGMD, -1.82%, Aurora Cannabis Inc. ACB, -2.99% (ACB), Canopy Growth Corporation CGC, -0.85%, Tilray, Inc. TLRY, -1.04%, Aphria, Inc. APHA, +0.82%

New York, NY, January 22, 2020 - Stock Market Press is a leading financial news company that delivers up to date news. Recap of eruptive news this week includes CBD Unlimited, Inc. EDXC, -1.39% reaching over 5,500 mass pharmacy and mass retail stores. Furthermore, we discuss Sugarmade, Inc. SGMD, -1.82%, Aurora Cannabis Inc. ACB, -2.99% (ACB), Canopy Growth Corporation CGC, -0.85%, Tilray, Inc. TLRY, -1.04%, Aphria, Inc. APHA, +0.82%.

Growing CBD markets

We mentioned edibles earlier, one of many CBD markets that's seeing huge interest by the general consumer, an area that CBD Unlimited, Inc. EDXC, -1.39% highlighted in their recent PR, an excerpt of which is included here:

CBD Unlimited Announces Fiscal Year-End Financial Results; Year-Over-Year Revenues Grow 88 Percent

Fiscal Year 2019 Milestones and Highlights:

International Expansion

* Cleared to Distribute CBD Products in Puerto Rico and South Africa.

* Accelerated registration in multiple international markets as the Company prepares for additional targeted channels abroad.

Increased Store Count Growth

* Surpassed year-end store goal by three months to more than 5,000 stores nationwide in mass pharmacy and mass retail markets.

* Accelerated store growth in the current quarter as stores are expanding their state rollout schedule. New contracted distributors are opening chain stores at 200-500 stores per launch.

* New Premium Blue Line BalmX and MistX installed in approximately 1,500 stores across 10 states.

* Established the foundation to service increased demand and to onboard stores on demand.

Product Innovation

* Closed deal with leading chocolate manufacturer, First Foods Group, Inc. (FIFG) to collaborate on premium hemp-based CBD food products.

* Invested and manufactured six Premium Blue Line SKUs at 35,000 units each.

* Reported wholesale value of the 6 premium products is valued over $5.5 million.

E-Commerce Advancement

* Reestablished Processing with two Major American Merchants.

* Increased its fulfillment capacity as the Company continues to grow its e-commerce presence.

Increased Tradeshow Presence

* Showcased its products at ECRM's Hemp/ CBD Health and Beauty Care Program where the Company was introduced to major retail buyers who extended commitments to the Company.

* Tradeshows in 2019 generated interest in the Company's products from approximately 50 leading retail stores across America.

Capital Markets

* Completed an audit of its financial statements for fiscal years 2018 and 2017 in order to pursue an up-listing to a higher OTC Market tier.

* Carries inventory on its books until the inventory is sold. The sale converts inventory into revenue instead of accounts receivable in certain Fortune 50 retailers.

Sugarmade, Inc. SGMD, -1.82% closed green on Tuesday after last weeks unexpected news of rescission of a recently closed, and long awaited, acquisition. Management saw the changing cannabis landscape would have them, and shareholders, better served headed in a new direction, which plans are already moving forward at a blistering pace.

The long road back for Aurora Cannabis Inc. ACB, -2.99% (ACB) could be getting started as the past week saw them climb back to 'life' after hitting $1.50 for a low. Aurora Cannabis Inc. ACB, -2.99% (ACB) closed down 5.6% on 38M vol traded.

Canopy Growth Corporation CGC, -0.85%, much like Aurora Cannabis Inc. ACB, -2.99% (ACB), while closing red for the day, saw stability return to the market during the last few hours of trading. One to watch here as it tests the $26 pivot point.

Recently announced expansion of their global leadership team saw Tilray, Inc. TLRY, -1.04% rally over the past week, closing up $5 at $21.09, from the chart bottom.

News of Aphria, Inc. APHA, +0.82% EU GMP certification gave the market a confirmation that business is set for growth, testing the resistance at the $5.60 level, a key trend reversal confirmation point.

Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

[gumzsa]

gm pros

[TradeForProfits]

$SGMD #cannabis #hemp #marijuana company stops RS, looks to 2020 corporate catapult

https://finance.yahoo.com/news/sugarmade-places-hold-reverse-split-133010143.html

Sugarmade Places on Hold Reverse Split - Plans to Enter Regulated Cannabis Market as Industry Turmoil Creates Opportunities
GlobeNewswire GlobeNewswireJanuary 22, 2020
NEW YORK, Jan. 22, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Sugarmade, Inc. (SGMD) (“Sugarmade”, “SGMD”, or the “Company”), today announces the Company has placed a hold on plans to complete a reverse split of its common shares. Pending a vote by its board of directors, management believes temporarily holding the reverse split or canceling the reverse split altogether may be the best future course of action. The Company is also announcing its planned entry into the regulated and licensed portion of the cannabis marketplace, with an emphasis on the California distribution and retail sectors.

Jimmy Chan, CEO of Sugarmade commented, “For at least the time being, we do not see a reason to move forward with the reverse stock split. However, we reserve the right, should circumstances warrant, to reactivate the reverse. We are in the process of modifying our business strategy to better align with where the cannabis marketplace is headed and thus our cancellation of the previously proposed transaction. We see significantly larger opportunities in the California cannabis distribution arena and have entered into advanced talks to make a strategic move into this area.”

The cannabis industry in California is rapidly evolving. As recently as only a few months ago, the competitive landscape for legal and licensed cultivators, processors, distributors and retailers was bleak, but the situation has rapidly improved as the crackdown on illegal market participants in California has shown great success. Sugarmade expects these successes to continue. Sugarmade sees a strong opportunity to enter this business arena as the environment changes and as long-time industry participants seek publicly traded partners.

The Company recently announced the rescission of an agreement to acquire a hydroponic equipment supplier. In a filing with the U.S. Securities & Exchange Commission, Sugarmade outlined that approximately 1.2 billion common share equivalents will be returned to the Company’s treasury. In addition, the rescission is estimated to save Sugarmade approximately $1 million per month over the next seven months. Sugarmade’s board of directors has determined the business combination was no longer viewed as the best shareholder maximization strategy as industry upheaval accelerates. Sugarmade has been presented with numerous other business combination opportunities that its board of directors now believes are superior and are under consideration.

The Company’s board of directors believes entry into the regulated portion of the cannabis business sector, which includes hemp and legal THC cannabis cultivation, processing and marketing, is particularly appealing due to the large number of assets within that sub-sector that are currently available for purchase or acquisition. Sugarmade has entered into discussion with several such companies relative to a strategic business combination.

About Sugarmade, Inc.

Sugarmade, Inc. (SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. For more information please reference www.sugarmade.com.

[TradeForProfits]

$IQST $16M 2019 revs announced, more for 2020 already on the books:

https://finance.yahoo.com/news/iqstel-inc-announces-etelix-fy-103010745.html

iQSTEL, Inc. Announces Etelix FY-2019 Revenue of $16,327,870 for Record Breaking Year
GlobeNewswire GlobeNewswireJanuary 22, 2020
NEW YORK, NY, Jan. 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- iQSTEL Inc. (IQST) announces record breaking year for its wholly owned subsidiary Etelix.

Mr. Iglesias, the Company’s CEO, stated: “The growth of our main and wholly-owned subsidiary Etelix continues to grow organically, well within the Company’s estimates. For the FY-2019 the Company finished with $16,327,870, an increase of 18.5% versus FY-2018. The main drivers for this growth have been excellent operational execution, as well as our continued quest for better pricing for our clients. The Company is now finalizing the final quarter revenue and operating profit for our recently acquired European subsidiary, Swisslink, which once consolidated will increase the Company’s consolidated revenue and operating profit considerably. We expect to have final revenue numbers in the coming March. Based on our excellent continued level of execution, we expect revenue and operating profit for our consolidated VoIP business to continue on a very robust growth rate through 2020 and the coming years.”

About iQSTEL Inc.:

iQSTEL (IQST) www.iQSTEL.com is a technology company offering a wide array of services to the Telecommunications Industry. These include services to International Long-Distance Telecommunications Operators (ILD Wholesale), Retail and Corporate markets (ILD Retail), Submarine Fiber Optic Network capacity, Satellite Communications services, Mobile Virtual Network Operator (MVNO) services, Internet of Things (IoT) technology solutions, Data Center facilities capacity leasing, and Blockchain solutions for the Telecommunications industry.

About Etelix.com USA, LLC:

Etelix.com USA LLC www.etelix.com is wholly owned subsidiary of iQSTEL Inc. Etelix.com USA, LLC is a Miami, Florida-based international telecom carrier founded in 2008 that provides telecom and technology solutions worldwide, with commercial presence in North America, Latin America and Europe. Enabled by its 214-license granted by the Federal Communications Commission (FCC), Etelix provides International Long-Distance voice services for Telecommunications Operators (ILD Wholesale), and Submarine Fiber Optic Network capacity for internet (4G and 5G). Etelix was founded in 2008 and has been profitable since inception.

About SwissLink Carrier AG:

SwissLink Carrier AG www.swisslink-carrier.com is a 51% owned subsidiary of iQSTEL Inc. SwissLink Carrier AG is a Switzerland based international Telecommunications Carrier founded in 2015 providing international VoIP connectivity worldwide, with commercial presence in Europe, CIS and Latin America. SwissLink Carrier AG is a Swiss licensed Operator, having a domestic Interconnect with Swisscom, allowing their international Carrier Customers direct terminations via SwissLink into all Switzerland Fix & Mobile Networks. Since the takeover from Swissphone in November 2018 and the rename into SwissLink, they operate on a profitable level.

Safe Harbor Statement: Statements in this news release may be "forward-looking statements". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and iQSTEL Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

iQSTEL Inc.

IR US Phone: [phone], IR Email: [e-mail]

Source: iQSTEL Inc.

www.iqstel.com ; www.swisslink-carrier.com and www.etelix.com

[gumzsa]

gn pros

[gumzsa]

EIPC .0013 back to lod

[gumzsa]

EIPC .0023

[gumzsa]

EIPC .0018

[gumzsa]

DFCO >05 News

Cox Introduced as Dalrada's Chief Engineering Officer
Appointment will bolster company's global technology efforts and bring advanced innovation to an international marketplace

HENDERSON, Nev., Jan. 21, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO) recently announced the appointment of Stuart Cox as Chief Engineering Officer. The move comes on the heels of the company's acquiring of Scotland-based low carbon, green energy company, Likido Limited.

As both the Chief Executive and Chief Technology Officer of Likido Limited, Cox brings award-winning and internationally-recognized expertise in engineering, heating, cooling, and renewables to the Dalrada team.

Additionally, with nearly 30 years of specialized experience in the fields of advanced mechanical processing, combustion systems, sustainable and renewable energy, and low carbon manufacturing, Cox has been at the forefront of the development of renewable energy systems featuring eco-friendly designs.

Cox has worked with global leaders in the pharmaceutical, nuclear enrichment, and fine chemical industries, and has collaborated with global companies including Schering-Plough, GlaxoSmithKline, Pfizer, AstraZeneca, and others. He holds a Higher National Certificate in Gas Utilization from Newham College in London, a Higher National Diploma in Gas Utilization from Oakland College in Hertfordshire, a Diploma in Management Studies from the University of Bedfordshire, and an Executive MBA from Cranfield University.

Dalrada's Chief Executive Officer, Brian Bonar, is pleased with the appointment, calling out Cox's outstanding resume and strong leadership abilities and adding, "Stuart will be a great asset to Dalrada. He has a lot of valuable experience and I have a lot of confidence in his abilities to help us move forward with our strategic goals."

"I'm excited to join Dalrada at a time when the company is expanding and developing cutting-edge products and advancing technology," said Cox. "I look forward to keeping the company's momentum going," he added.

Cox will be tasked with heading up engineering for all of Dalrada's development projects, including the heating and cooling of supercritical CO2 units. He'll also lead the engineering efforts for Dalrada's innovative extraction machine.

About Dalrada Financial

Dalrada Financial Corp. (OTC Pink: DFCO) solves real-world problems by producing innovation-focused and technologically-centered solutions on a global level. Delivering next-generation manufacturing, engineering, and healthcare products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of financial capital. The company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. For more information, please visit www.dalrada.com or call 1-858-283-1253.

About Likido Limited

Likido is an international technology company, developing advanced solutions for the harvesting and recycling of energy. Using its novel heat pump systems (patent pending), Likido is revolutionizing the renewable energy sector with the provision of innovative modular process technologies to maximize the capture and reuse of thermal energy for integrated heating and cooling applications. With uses across industrial, commercial and residential sectors Likido seeks to provide cost savings and to minimize carbon emissions across supply chains. Likido's novel technologies enable the effective recovery and recycling of process energy, mitigating against climate change and enhancing quality of life through the provision of low-carbon heating and cooling systems. For more information, please visit www.likido.net.

Disclaimer

Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.



https://c212.net/c/img/favicon.png?sn=LA95571&sd=2020-01-21 View original content:http://www.prnewswire.com/news-releases/cox-introduced-as-dalradas-chief-engineering-officer-300990017.html

SOURCE Dalrada Financial Corp.

[gumzsa]

gm pros

[gumzsa]

gn pros

[TradeForProfits]

$SGMD #cannabis #hemp, targets profitability, cancels $1M cash outlay:

News: https://finance.yahoo.com/news/sugarmade-see-superior-opportunities-rescinds-130010390.html

8K rescision: https://www.otcmarkets.com/filing/html?id=13849470&guid=5ILjUKebBfrUrth

Sugarmade – “We See Superior Opportunities” - Rescinds Agreement - Saving 1.2 Billion Share Issuance and $1 MM Quarterly Cash Outlay

GlobeNewswire GlobeNewswireJanuary 17, 2020
NEW YORK, Jan. 17, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Sugarmade, Inc. (SGMD) (“Sugarmade”, “SGMD”, or the “Company”), today announces the rescission of an agreement to acquire a hydroponic equipment supplier. In a filing with the U.S. Securities & Exchange Commission, Sugarmade outlines that approximately 1.2 billion common share equivalents will be returned to the Company’s treasury. Sugarmade’s board of directors has determined the business combination is no longer viewed as the best shareholder maximization strategy as industry upheaval accelerates. Sugarmade has been presented with numerous other business combination opportunities that its board of directors now believes are superior and are under consideration.

The rescission will:

Reduce the outstanding shares to approximately 706 million via the return of approximately 1.2 billion shares to SGMD’s treasury.
Result in a cash flow savings of $1 million quarter for seven quarters due to the elimination of the cash portion of the transaction due.
Eliminate shareholder dilution due to the acquisition’s insufficient cash flow to meet debt service.
Allow Sugarmade to immediately enter the significantly higher margin regulated sectors of the cannabis marketplace where acquisition targets are plentiful and are priced at meaningful discounts.
“The hydroponic transaction was proposed more than two years ago and since that time the industry has changed significantly. Simply Put - We have looked long and hard at the industry situation and we have determined there are numerous other potentially larger opportunities at this time for Sugarmade and its shareholders,” commented CEO Jimmy Chan. “The previous transaction is not the best way for us to maximize shareholder value. We are very pleased to be returning all of the issued shares to the treasury, which significantly lowers our outstanding shares, placing us in a prime spot as an industry consolidator of the many troubled assets in the sector. Thus, as a board of directors, we are taking the bold step to rescind the Past of the industry in favor of the Future of the industry and the more lucrative opportunities that are currently under consideration.”

The shareholders of the acquired company have agreed to surrender 448,873,817 common shares and 750,000 Series B Convertible Preferred shares. On an as-converted to common basis the returns to Sugarmade’s treasury equal 448,873,817 relating to the common shares to be surrendered and 750,000,000 million common shares equivalents due to each Series B Convertible Preferred share converting to common shares on a 1 for 1,000 basis. Thus, on a common share equivalent basis, the surrender equals 1,198,873,817 common shares, if all Preferred Series B were converted.

Additionally, as part of the Agreement, the Company will retain or will receive 102,248 shares in the acquired company.

A major factor in the decision to rescind the transaction is the significant upheaval currently being seen within the marketplace as many cultivators, distributors, vendors and other market participants struggle to maintain viability. This industry turmoil has caused many struggling companies to seek publicly traded partners that can assist in their return to viability. Sugarmade has entered into discussions with representatives of several of these companies operating in the regulated portion of the cannabis sector.

The Company’s board of directors believes entry into the regulated portion of the cannabis business sector, which includes hemp and legal THC cannabis cultivation, processing and marketing, is particularly appealing due to the large number of assets within that sub-sector that are currently available for purchase or acquisition.

About Sugarmade, Inc.
Sugarmade, Inc. (SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. For more information please reference www.sugarmade.com

FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others. such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Corporate Contact:
Jimmy Chan
[phone]
[e-mail]

Corporate Wire Service:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[e-mail]

[gumzsa]

gm pros

[gumzsa]

gn pros

[TradeForProfits]

$MCTC 'recently filed five #patents on #hemp extract technologies and delivery systems':

https://finance.yahoo.com/news/mctc-announces-thc-v-skinny-123000210.html

MCTC Announces THC-V Skinny Cannabinoid Project Varin for THC-V Nanoparticles and Glycosides
ACCESSWIRE ACCESSWIREJanuary 16, 2020
LOS ANGELES, CA / ACCESSWIRE / January 16, 2020 / MCTC Holdings, Inc. (OTC PINK:MCTC), a cannabinoid science forward company developing unique infusion technologies and cannabinoid delivery systems, today announces Project Varin, a program to develop new delivery systems for Tetrahydrocannabivarin (THC-V). THC-V is becoming known within the cannabinoid sciences arena as the "Skinny Cannabinoid" due to its purported appetite suppression qualities, and its possible use as a treatment against obesity-associated glucose intolerance. THC-V is a rare cannabinoid found in the Cannabis Sativa plant. THC-V is not scheduled as a controlled substance at the federal level and is only recently available in the marketplace.

Arman Tabatabaei, CEO of MCTC Holdings, Inc. commented: "THC-V is so rare and difficult to obtain, it is currently valued at around $500,000 per kilogram, which is approximately ten times the price of gold. In order for the marketplace to utilize this potentially beneficial exotic cannabinoid, new delivery systems will need to be developed to allow the amount of THC-V administered to be efficiently utilized by the human body. This issue of bioavailability has been a significant ongoing concern for the industry relative to many cannabinoids, but with the rarity of THC-V, the need for efficient delivery is hugely amplified. It is our goal to solve this pressing industry issue. Based on our already completed laboratory accomplishments and our patent-pending technologies, we believe this goal is within our reach."

The primary goal of this groundbreaking research by MCTC will be to develop THC-V delivery methods that significantly improve bioavailability. In the first stage of the program, which started this week, researchers plan to produce THC-V polymeric nanoparticles and nanofibers based on the Company's patent-pending technologies. Over the past few months, the Company has realized considerable success in producing Cannabidiol (CBD) particles, which the Company's researchers believe is highly leverageable relative to THC-V particle creation. In the second phase of development, which is scheduled to begin in March of 2020, the Company plans to apply its ongoing cannabinoid glycosides research to THC-V, in order to produce THC-V with unparalleled levels of availability at minimal usage levels.

Mr. Tabatabaei continued: "Interest in THC-V and Cannabinol (CBN) is quickly growing within the cannabinoid industry, and we believe both will be important topics throughout 2020 and beyond. With the recent availability of nearly 100% pure research quantities of these exotic cannabinoids now hitting the marketplace and the peaking interest, we believe our timing in launching Project Varin is optimal. We have made great strides in only a few months relative to cannabinoid research. We plan to apply what we have learned and our new patent-pending technologies to THC-V and eventually to CBN."

The Company has recently filed five patents on hemp extract technologies and delivery systems. MCTC is currently working with patent counsel to protect various other aspects of its other new technologies. As previously announced, the Company plans to continue other areas of delivery systems research including its programs pertaining to cannabinoid glycosides, polymeric cannabinoid nanoparticles and nanofibers, and its hemp extract-based alcohol replacement technologies.

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

More information on the Company can be viewed at www.CannabisGlobalinc.com.

For more information, please contact:

Arman Tabatabaei

[e-mail]

[TradeForProfits]

$MCTC #THC-V runs $500k/kg, efficient delivery system being developed:

https://finance.yahoo.com/news/mctc-announces-thc-v-skinny-123000210.html

MCTC Announces THC-V Skinny Cannabinoid Project Varin for THC-V Nanoparticles and Glycosides
ACCESSWIRE ACCESSWIREJanuary 16, 2020
LOS ANGELES, CA / ACCESSWIRE / January 16, 2020 / MCTC Holdings, Inc. (OTC PINK:MCTC), a cannabinoid science forward company developing unique infusion technologies and cannabinoid delivery systems, today announces Project Varin, a program to develop new delivery systems for Tetrahydrocannabivarin (THC-V). THC-V is becoming known within the cannabinoid sciences arena as the "Skinny Cannabinoid" due to its purported appetite suppression qualities, and its possible use as a treatment against obesity-associated glucose intolerance. THC-V is a rare cannabinoid found in the Cannabis Sativa plant. THC-V is not scheduled as a controlled substance at the federal level and is only recently available in the marketplace.

Arman Tabatabaei, CEO of MCTC Holdings, Inc. commented: "THC-V is so rare and difficult to obtain, it is currently valued at around $500,000 per kilogram, which is approximately ten times the price of gold. In order for the marketplace to utilize this potentially beneficial exotic cannabinoid, new delivery systems will need to be developed to allow the amount of THC-V administered to be efficiently utilized by the human body. This issue of bioavailability has been a significant ongoing concern for the industry relative to many cannabinoids, but with the rarity of THC-V, the need for efficient delivery is hugely amplified. It is our goal to solve this pressing industry issue. Based on our already completed laboratory accomplishments and our patent-pending technologies, we believe this goal is within our reach."

The primary goal of this groundbreaking research by MCTC will be to develop THC-V delivery methods that significantly improve bioavailability. In the first stage of the program, which started this week, researchers plan to produce THC-V polymeric nanoparticles and nanofibers based on the Company's patent-pending technologies. Over the past few months, the Company has realized considerable success in producing Cannabidiol (CBD) particles, which the Company's researchers believe is highly leverageable relative to THC-V particle creation. In the second phase of development, which is scheduled to begin in March of 2020, the Company plans to apply its ongoing cannabinoid glycosides research to THC-V, in order to produce THC-V with unparalleled levels of availability at minimal usage levels.

Mr. Tabatabaei continued: "Interest in THC-V and Cannabinol (CBN) is quickly growing within the cannabinoid industry, and we believe both will be important topics throughout 2020 and beyond. With the recent availability of nearly 100% pure research quantities of these exotic cannabinoids now hitting the marketplace and the peaking interest, we believe our timing in launching Project Varin is optimal. We have made great strides in only a few months relative to cannabinoid research. We plan to apply what we have learned and our new patent-pending technologies to THC-V and eventually to CBN."

The Company has recently filed five patents on hemp extract technologies and delivery systems. MCTC is currently working with patent counsel to protect various other aspects of its other new technologies. As previously announced, the Company plans to continue other areas of delivery systems research including its programs pertaining to cannabinoid glycosides, polymeric cannabinoid nanoparticles and nanofibers, and its hemp extract-based alcohol replacement technologies.

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The Company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs.

More information on the Company can be viewed at www.CannabisGlobalinc.com.

For more information, please contact:

Arman Tabatabaei

[e-mail]

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[StockHighAlert-]

$ERBB is starting to see major topline growth, with quarterly y/y revs increasing at 481%.

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

DFCO >05 news

Dalrada Appoints Chief Operating Officer
New appointment will strengthen strategic global initiatives and priorities


HENDERSON, Nev., Jan. 9, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO) announced today that Fawad Nisar has been appointed Chief Operating Officer. Reporting to Chief Executive Officer, Brian Bonar, Nisar will be responsible for the day-to-day management of all global operations for Dalrada Financial and its subsidiaries.

Nisar was previously the Executive Vice President at Trucept Marketing and was responsible for optimizing profits and sales strategies for customers in various B2B and B2C industries. Nisar has been highly engaged as a consultant to Dalrada providing sound business strategy over the last six months. "Fawad's background and experience in launching and managing the expansion of products and services give me complete confidence in his ability to advance all aspects of our operations," said Bonar. "During his time as a business consultant, he has proven himself as a seasoned and trusted leader focused on accountability and generating results. I look forward to working with Fawad closely," Bonar added.

Prior to his most recent position, Fawad held various executive and high-level roles managing global operations, as well as sales and marketing for large product and service organizations. Graduating with a master's degree in chemical engineering from Manhattan College, Nisar began his career working as a biochemical engineer for Wyeth Pharmaceuticals – producing one of the first targeted chemotherapy drugs to treat acute myeloid leukemia, followed by 14 years of providing business solutions to Fortune 500 pharmaceutical, healthcare, manufacturing, and retail businesses.

"Joining Dalrada at this juncture is very exciting given the possibilities for growth and expansion. The business offerings have strategically come together aligning with my passions of business strategy, healthcare, and technology," said Nisar.

About Dalrada Financial

Dalrada Financial Corp. (OTC Pink: DFCO) solves real-world problems by producing innovation-focused and technologically-centered solutions on a global level. Delivering next-generation manufacturing, engineering, and healthcare products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of financial capital. The company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. For more information, please visit www.dalrada.com or call 1-858-283-1253.

Disclaimer

Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.

Cision View original content:http://www.prnewswire.com/news-releases/dalrada-appoints-chief-operating-officer-300984102.html

SOURCE Dalrada Financial Corp.

[gumzsa]

gn pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[gumzsa]

gn pros

[pennyonfire]

$NBCO 1.92

[gumzsa]

gm pros

[gumzsa]

gn pros

[gumzsa]

gm pros

[BottomBounce]

$NIO AH Breakout Alert

[BottomBounce]

HYSR nice one

[gumzsa]

gn pros

[StockHighAlert-]

$MINE MINERCO,INC also known as Mushrooms International Enterprises OTC:MINE is the worlds first publicly traded company focused on the research, production and distribution of psilocybin mushrooms. In addition MINERCO seeks to acquire and invest in CBD operating companies extraction, edibles, topicals, white label products etc. https://www.minercoinc.com/

[pennyonfire]

Gm

[gumzsa]

gm pros